Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative.
Deependra Singh, Jerome Vignat, Valentina Lorenzoni...
https://pubmed.ncbi.nlm.nih.gov/36528031/Actively Recruiting
Led by Tata Memorial Hospital · Updated on 2026-02-09
1000
Participants Needed
5
Research Sites
9 weeks
Total Duration
Gynecological cancer, particularly cervical cancer, is a significant health challenge in Asia, causing many deaths due to limited preventive care, screening, and cultural delays in seeking treatment. This research focuses on advanced cervical cancer patients treated with radiation and chemotherapy followed by internal radiation called brachytherapy. While advanced brachytherapy methods have shown good results in Western countries, there is a lack of data on their use and outcomes in Asian populations, leading to inconsistent treatment practices. The Asian Gynecological Brachytherapy Registry ABGR is a collaborative effort collecting data from multiple centers across Asia. It uses a retrospective cohort design to include patients treated over a 12-month period with different brachytherapy techniques and imaging methods. The registry also gathers information on external radiation, chemotherapy, treatment timing, patient demographics, and treatment planning variations. This comprehensive data aims to understand treatment patterns, outcomes, and factors influencing care across Asian healthcare settings. Participants medical records will be reviewed to record the types of brachytherapy and radiation treatments used, chemotherapy doses, treatment schedules, and side effects over a three-year period. The study will measure outcomes such as local and regional cancer control, disease-free survival, and radiation-related adverse events. Data quality and patient privacy are maintained through strict protocols, and the findings will support future improvements in cervical cancer care in Asia.
CONDITIONS
Asian Gynecological Brachytherapy Registry in Cervical Cancer
D
Dr. Supriya Chopra
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Tata Memorial Hospital
Lead Sponsor
Chiang Mai University, Thailand
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants who have received brachytherapy and concurrent treatments are observed to record treatment patterns, clinical outcomes, and adverse events over time.
Follow-up visits as per routine care
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Deependra Singh, Jerome Vignat, Valentina Lorenzoni...
https://pubmed.ncbi.nlm.nih.gov/36528031/Varsha Hande, Supriya Chopra, Alfredo Polo...
https://pubmed.ncbi.nlm.nih.gov/37694176/Maximilian P Schmid, Jacob C Lindegaard, Umesh Mahantshetty...
https://pubmed.ncbi.nlm.nih.gov/36599120/Ekkasit Tharavichitkul, Chate Sivasomboon, Somsak Wanwilairat...
https://pubmed.ncbi.nlm.nih.gov/22277978/Umesh Mahantshetty, Rahul Krishnatry, Vinod Hande...
https://pubmed.ncbi.nlm.nih.gov/29280456/Prachi Mittal, Supriya Chopra, Sidharth Pant...
https://pubmed.ncbi.nlm.nih.gov/30085892/Ekkasit Tharavichitkul, Bongkot Jia-Mahasap, Pooriwat Muangwong...
https://pubmed.ncbi.nlm.nih.gov/35719089/Richard Pötter, Kari Tanderup, Maximilian Paul Schmid...
https://pubmed.ncbi.nlm.nih.gov/33794207/Ekkasit Tharavichitkul, Somvilai Mayurasakorn, Vicharn Lorvidhaya...
https://pubmed.ncbi.nlm.nih.gov/21952319/Naoya Murakami, Ken Ando, Masumi Murata...
https://pubmed.ncbi.nlm.nih.gov/35446962/Tata Memorial Hospital
Lead Sponsor
Chiang Mai University, Thailand
Collaborating Sponsor